120 related articles for article (PubMed ID: 8650074)
1. There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue.
Epner DE; Coffey DS
Prostate; 1996 Jun; 28(6):372-8. PubMed ID: 8650074
[TBL] [Abstract][Full Text] [Related]
2. Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma.
Epner DE; Partin AW; Schalken JA; Isaacs JT; Coffey DS
Cancer Res; 1993 May; 53(9):1995-7. PubMed ID: 8481901
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of caveolin is associated with prostate and breast cancer.
Yang G; Truong LD; Timme TL; Ren C; Wheeler TM; Park SH; Nasu Y; Bangma CH; Kattan MW; Scardino PT; Thompson TC
Clin Cancer Res; 1998 Aug; 4(8):1873-80. PubMed ID: 9717814
[TBL] [Abstract][Full Text] [Related]
5. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer.
Rondinelli RH; Epner DE; Tricoli JV
Prostate Cancer Prostatic Dis; 1997 Dec; 1(2):66-72. PubMed ID: 12496918
[TBL] [Abstract][Full Text] [Related]
6. Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors.
Halin S; Wikström P; Rudolfsson SH; Stattin P; Doll JA; Crawford SE; Bergh A
Cancer Res; 2004 Aug; 64(16):5664-71. PubMed ID: 15313905
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
8. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
9. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
Upadhyay J; Shekarriz B; Nemeth JA; Dong Z; Cummings GD; Fridman R; Sakr W; Grignon DJ; Cher ML
Clin Cancer Res; 1999 Dec; 5(12):4105-10. PubMed ID: 10632347
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer.
Masuda H; Fukabori Y; Nakano K; Takezawa Y; CSuzuki T; Yamanaka H
Prostate; 2003 Mar; 54(4):268-74. PubMed ID: 12539225
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R
Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581
[TBL] [Abstract][Full Text] [Related]
12. mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue.
Jung M; Römer A; Keyszer G; Lein M; Kristiansen G; Schnorr D; Loening SA; Jung K
Prostate; 2003 May; 55(2):89-98. PubMed ID: 12661033
[TBL] [Abstract][Full Text] [Related]
13. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma.
Schek N; Hall BL; Finn OJ
Cancer Res; 1988 Nov; 48(22):6354-9. PubMed ID: 3180054
[TBL] [Abstract][Full Text] [Related]
14. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.
Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB
Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373
[TBL] [Abstract][Full Text] [Related]
16. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer.
Winter RN; Kramer A; Borkowski A; Kyprianou N
Cancer Res; 2001 Feb; 61(3):1227-32. PubMed ID: 11221855
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF.
Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW
Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244
[TBL] [Abstract][Full Text] [Related]
18. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
19. Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens.
Guo X; Knudsen BS; Peehl DM; Ruiz A; Bok D; Rando RR; Rhim JS; Nanus DM; Gudas LJ
Cancer Res; 2002 Mar; 62(6):1654-61. PubMed ID: 11912136
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines.
Ornstein DK; Gillespie JW; Paweletz CP; Duray PH; Herring J; Vocke CD; Topalian SL; Bostwick DG; Linehan WM; Petricoin EF; Emmert-Buck MR
Electrophoresis; 2000 Jun; 21(11):2235-42. PubMed ID: 10892734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
